Inflammatory breast cancer appearance at presentation is associated with overall survival

被引:7
|
作者
Balema, Wintana [1 ,2 ,3 ]
Liu, Diane [4 ]
Shen, Yu [4 ]
El-Zein, Randa [5 ]
Debeb, Bisrat G. [1 ,6 ]
Kai, Megumi [2 ,3 ]
Overmoyer, Beth [7 ]
Miller, Kathy D. [8 ]
Le-Petross, Huong T. [2 ,3 ]
Ueno, Naoto T. [1 ,6 ]
Woodward, Wendy A. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Morgan Welch IBC Clin, Dept Radiat Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Res Program, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Houston Methodist Canc Ctr, Dept Radiol, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源
CANCER MEDICINE | 2021年 / 10卷 / 18期
关键词
breast cancer; breast swelling; erythema; IBC; peau d'orange; redness; skin thickening; T4D; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; CLINICAL MANAGEMENT; DIAGNOSIS; LYMPHANGIOGENESIS; CARCINOMA; CONSENSUS; CENTERS; PROGRAM; BIOLOGY; TIME;
D O I
10.1002/cam4.4170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Inflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a "classic" triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, with overall survival (OS). Method Breast medical photographs from patients enrolled on a prospective IBC registry were scored by two independent reviewers as classic (triad above), not classic, and difficult to assign. Chi-squared test, Fisher's exact test, and Wilcoxon rank-sum test were used to assess differences between patient groups. Kaplan-Meier estimates and the log-rank test and Cox proportional hazard regression were used to assess the OS. Results We analyzed 245 IBC patients with median age 54 (range 26-81), M0 versus M1 status (157 and 88 patients, respectively). The classic triad was significantly associated with smoking, post-menopausal status, and metastatic disease at presentation (p = 0.002, 0.013, and 0.035, respectively). Ten-year actuarial OS for not classic and difficult to assign were not significantly different and were grouped for further analyses. Ten-year OS was 29.7% among patients with the classic sign triad versus 57.2% for non-classic (p < 0.0001). The multivariate Cox regression model adjusting for clinical staging (p < 0.0001) and TNBC status (<0.0001) demonstrated classic presentation score significantly associated with poorer OS time (HR 2.6, 95% CI 1.7-3.9, p < 0.0001). Conclusions A triad of classic IBC signs independently predicted OS in patients diagnosed with IBC. Further work is warranted to understand the biology related to clinical signs and further extend the understanding of physical examination findings in IBC.
引用
收藏
页码:6261 / 6272
页数:12
相关论文
共 50 条
  • [41] Nomograms for prediction of overall and cancer-specific survival in young breast cancer
    Yi Sun
    Yuqiang Li
    Jiannan Wu
    Huan Tian
    Huanhuan Liu
    Yingqing Fang
    Yudong Li
    Fengyan Yu
    Breast Cancer Research and Treatment, 2020, 184 : 597 - 613
  • [42] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
  • [43] The effect of exercise on disease-free survival and overall survival in patients with breast cancer
    Akdeniz, Nadiye
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Lacin, Sahin
    Ceylan, Emre Husnu
    Isikdogan, Abdurrahman
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (04) : 1587 - 1597
  • [44] Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer
    Pohl, A.
    Azuma, M.
    Zhang, W.
    Yang, D.
    Ning, Y.
    Winder, T.
    Danenberg, K.
    Lenz, H-J
    PHARMACOGENOMICS JOURNAL, 2011, 11 (02) : 93 - 99
  • [45] Survival pattern in male breast cancer: distinct from female breast cancer
    Gwark, Sungchan
    Kim, Jisun
    Chung, Il Yong
    Kim, Hee Jeong
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei Hyun
    Lee, Sae Byul
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer
    Winham, Stacey J.
    Pirie, Ailith
    Chen, Yian Ann
    Larson, Melissa C.
    Fogarty, Zachary C.
    Earp, Madalene A.
    Anton-Culver, Hoda
    Bandera, Elisa V.
    Cramer, Daniel
    Doherty, Jennifer A.
    Goodman, Marc T.
    Gronwald, Jacek
    Karlan, Beth Y.
    Kjaer, Susanne K.
    Levine, Douglas A.
    Menon, Usha
    Ness, Roberta B.
    Pearce, Celeste L.
    Pejovic, Tanja
    Rossing, Mary Anne
    Wentzensen, Nicolas
    Bean, Yukie T.
    Bisogna, Maria
    Brinton, Louise A.
    Carney, Michael E.
    Cunningham, Julie M.
    Cybulski, Cezary
    Defazio, Anna
    Dicks, Ed M.
    Edwards, Robert P.
    Gayther, Simon A.
    Gentry-Maharaj, Aleksandra
    Gore, Martin
    Iversen, Edwin S.
    Jensen, Allan
    Johnatty, Sharon E.
    Lester, Jenny
    Lin, Hui-Yi
    Lissowska, Jolanta
    Lubinski, Jan
    Menkiszak, Janusz
    Modugno, Francesmary
    Moysich, Kirsten B.
    Orlow, Irene
    Pike, Malcolm C.
    Ramus, Susan J.
    Song, Honglin
    Terry, Kathryn L.
    Thompson, Pamela J.
    Tyrer, Jonathan P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03) : 446 - 454
  • [47] Breast cancer survival prediction using seven prognostic biomarker genes
    Liu, Liu
    Chen, Zhilin
    Shi, Wenjie
    Liu, Hui
    Pang, Weiyi
    ONCOLOGY LETTERS, 2019, 18 (03) : 2907 - 2916
  • [48] Malignant change in a massive pleomorphic adenoma resembling the presentation of advanced inflammatory breast cancer
    Seager, Leonie
    Colbert, Serryth
    Spedding, Anne V.
    Brennan, Peter A.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2012, 50 (03) : 266 - 267
  • [49] A Nomogram To Predict The Overall Survival Of Breast Cancer Patients And Guide The Postoperative Adjuvant Chemotherapy In China
    Wang, Xin
    Feng, Ziwei
    Huang, Yubei
    Li, Haixin
    Cui, Ping
    Wang, Dezheng
    Dai, Hongji
    Song, Fangfang
    Zheng, Hong
    Wang, Peishan
    Cao, Xuchen
    Gu, Lin
    Zhang, Jin
    Song, Fengju
    Chen, Kexin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10029 - 10039
  • [50] Survival Analysis of Patients with Inflammatory Breast Cancer in Relation to Clinical and Histopathological Characteristics
    Preda, Marius
    Ilina, Razvan
    Potre, Ovidiu
    Potre, Cristina
    Mazilu, Octavian
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12447 - 12455